NanoGhost

NanoGhostNanoGhost
NanoGhost

NanoGhost

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Website
DR 122019Active11Tel Aviv, Israel
Rate
Advertise here

About

NanoGhost is a biotechnology company focused on developing a highly selective, first-in-class drug delivery platform. Their platform, 'Nano-Ghosts' (NGs), is derived from the cell membrane of mesenchymal stem cells (MSCs), which naturally target cancer and sites of inflammation. This versatile technology aims to provide highly selective drug targeting for various therapeutic applications.
Frequently asked

What does NanoGhost do?

NanoGhost is a biotechnology company focused on developing a highly selective, first-in-class drug delivery platform. Their platform, 'Nano-Ghosts' (NGs), is derived from the cell membrane of mesenchymal stem cells (MSCs), which naturally target cancer and sites of inflammation. This versatile technology aims to provide highly selective drug targeting for various therapeutic applications.

What is NanoGhost's revenue?

StartupHub estimates NanoGhost's annual revenue at $1.9M (range $1.0M to $2.9M, 64% confidence), based on comparable companies in the sector.

Where is NanoGhost headquartered?

NanoGhost is headquartered in Tel Aviv, Israel.

When was NanoGhost founded?

NanoGhost was founded in 2019.

What industry does NanoGhost operate in?

NanoGhost operates in Life Sciences, Drug Delivery, Biotech, Oncology, Immunology, Drug Discovery.

How many employees does NanoGhost have?

NanoGhost has approximately 11 people on record.

HEADCOUNT
11
DOMAIN RATING
12
Comments

No comments yet. Be the first to share your take.